349 results on '"Wehkamp J"'
Search Results
2. Reduced Paneth cell alpha-defensins in ileal Crohn's disease
3. Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide
4. Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin
5. S230: HUMAN ΒETA-DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT-VERSUS-HOST DISEASE
6. P563 Psychotherapy experience and demand for it and their association in inflammatory bowel disease – results from an internet-based survey
7. DOP083 Recombinant subcutaneous human beta-Defensin 2 (hBD2) ameliorates experimental colitis in different in vivo models
8. A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa
9. Chronic Heavy Alcohol Use is Associated with Upregulated Paneth Cell Antimicrobials in Gastric Mucosa
10. Labordiagnostik bei chronisch-entzündlichen Darmerkrankungen, einschließlich Blut- und Stuhldiagnostik
11. Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans
12. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease
13. Human β-defensin-2 suppresses key features of asthma in murine models of allergic airways disease
14. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal a-defensin expression
15. Innate Immunity and Colonic Inflammation: Enhanced Expression of Epithelial α-Defensins
16. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to helicobacter pylori status. (Original Article)
17. A peptide derived from the highly conserved protein GAPDH is involved in tissue protection by different antifungal strategies and epithelial immunomodulation
18. Role of defensins in fungal (candida) infections
19. Innate immune dysfunction in inflammatory bowel disease
20. Teduglutide treatment for chronic intestinal failure patients in germany – insights from a patient home care service program
21. Bundesweite, multizentrische Studie zur Behandlung mit Teduglutid bei Kurzdarmpatienten in Deutschland - Erkenntnisse aus einem Patientenversorgungsprogramm
22. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus
23. Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohnʼs disease
24. Clarification
25. Decreased Paneth cell defensin expression in ileal Crohn’s disease is independent of inflammation, but linked to the NOD2 1007fs genotype
26. Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2
27. This title is unavailable for guests, please login to see more information.
28. This title is unavailable for guests, please login to see more information.
29. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
30. Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype
31. MON-PO361: Results of a Multicentric Retrolective Study of Teduglutide Treatment in Benign Short Bowel Syndrome in Germany
32. Bundesweite, multizentrische und retrolektive Studie zur Behandlung mit Teduglutid bei Kurzdarmpatienten
33. Ustekinumab-Serumspiegel sind mit klinischem Ansprechen korreliert – Real-World-Daten einer regionalen multizentrischen Untersuchung an Patienten mit M. Crohn
34. This title is unavailable for guests, please login to see more information.
35. Humanes beta Defensin-2 führt zur reversiblen Zunahme der mikrobiellen Diversität und verbessert die Symptomatik bei experimentell induzierter Colitis
36. Humane gastrointestinale Proteasen generieren aus humanen beta-Defensin 1 eine mögliche therapeutische Alternative gegen Candidose
37. Bacterial Periplasmic Oxidoreductases Control the Activity of Oxidized Human Antimicrobial β-Defensin 1
38. Bacterial Periplasmic Oxidoreductases Control the Activity of Oxidized Human Antimicrobial β-Defensin 1
39. Accounting for institutional quality in global forest modeling
40. Escaping the climate policy uncertainty trap: options contracts for REDD+
41. P669 Human β-defensin 2 suppresses TNF-α secretion in human and mouse dendritic cells mediated by chemokine receptor-2
42. P498 Crohn’s disease patient’s isolated classical monocytes are characterised by reduced secretion of Wnt-ligands affecting Paneth cell antimicrobial host defense
43. P851 Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitis
44. P489 Clinical experience with ustekinumab in selected Crohn's disease patients
45. Rekombinantes subkutanes humanes beta-Defensin 2 (hBD2) lindert die experimentell induzierte Colitis in verschiedenen Mausmodellen in vivo
46. Rekombinantes orales humanes beta-Defensin 2 (hBD2) verbessert signifikant die experimentell induzierte Colitis in vivo
47. Bakterielle periplasmatische Reduktasen kontrollieren die Aktivität von oxidiertem humanem ß- Defensin 1 in Gram-negativen Bakterien
48. Rezeptor – Expression des GLP-2-Rezeptors im Dickdarm als molekulare Basis für klinische Effekte von Teduglutide bei Kurzdarmpatienten mit Dickdarmkontinuität
49. Hornerin – ein Barriereprotein mit pathophysiologischer Bedeutung bei Chronisch Entzündlichen Darmerkrankungen (CED)?
50. Taking Differences in Institutional Quality into Account in Global Forest Modelling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.